Top compounds associated with response to CRK


Feature Type Standardized
Nominal ANOVA
mRNA Elesclomol GDSC1000 pan-cancer AAC 0.19 5e-06
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 5e-05
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 0.0001
mRNA Doxorubicin gCSI pan-cancer AAC 0.23 0.0003
mRNA Nutlin-3a (-) GDSC1000 pan-cancer AAC 0.15 0.0003
mRNA JNK-9L GDSC1000 pan-cancer AAC 0.15 0.0003
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 0.0003
mRNA thapsigargin GDSC1000 pan-cancer AAC 0.15 0.0004
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.15 0.0005
mRNA 17-AAG GDSC1000 pan-cancer AAC 0.13 0.0009
Download CSV